Table 3.
Evaluation with Cox Regression Analysis of the Factors Affecting the Hazard Ratio of The Patients
Group | 95% | CI | ||||
---|---|---|---|---|---|---|
n | β | p | HR | Min | Max | |
Age | ||||||
<64 (Ref) | 240 | 0.45 | 0.003 | 1 | ||
≥65 | 112 | 1.568 | 1.163 | 2.112 | ||
Type | ||||||
Adeno cell (Ref) | 99 | 1 | ||||
Nos | 76 | 0.517 | 0.008 | 1.677 | 1.147 | 2.452 |
Squamous cell | 106 | -0.142 | 0.457 | 0.868 | 0.596 | 1.262 |
Small cell | 71 | 0.818 | <0.001 | 2.265 | 1.549 | 3.313 |
Stage | ||||||
≤3+limited (Ref) | 190 | 0.813 | <0.001 | 1 | ||
4+common | 162 | 2.254 | 1.709 | 2.972 | ||
NLR | ||||||
<3 (Ref) | 160 | 0.303 | 0.031 | 1 | ||
≥3 | 192 | 1.354 | 1.028 | 1.783 | ||
ECOG | ||||||
0 (Ref) | 258 | |||||
1 | 88 | 0.107 | 0.528 | 1.112 | 0.799 | 1.549 |
2 | 6 | -0.001 | 0.999 | 0.999 | 0.363 | 2.749 |
Hb | 386 | -0.119 | 0.008 | 0.898 | 0.813 | 0.97 |
L | 386 | -0.055 | <0.001 | 0.947 | 0.919 | 0.976 |
Hb, Haemoglobin; L, Lymphocyte; NLR, Neutrophil to lymphocyte ratio; Ecog, Eastern Cooperative Oncology Group